These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1773 related articles for article (PubMed ID: 19336687)

  • 41. [Amylin/IAPP (islet amyloid polypeptide)--physiology and clinical significance].
    Ludvik B
    Wien Klin Wochenschr; 1997 Jun; 109(11):379-83. PubMed ID: 9281227
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of the p53 tumor suppressor in metabolism and diabetes.
    Kung CP; Murphy ME
    J Endocrinol; 2016 Nov; 231(2):R61-R75. PubMed ID: 27613337
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of insulin in glucose-stimulated insulin secretion in beta cells.
    Goren HJ
    Curr Diabetes Rev; 2005 Aug; 1(3):309-30. PubMed ID: 18220607
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of islet amyloid in type 2 diabetes mellitus.
    Höppener JW; Lips CJ
    Int J Biochem Cell Biol; 2006; 38(5-6):726-36. PubMed ID: 16459127
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progressive erosion of β-cell function precedes the onset of hyperglycemia in the NOD mouse model of type 1 diabetes.
    Ize-Ludlow D; Lightfoot YL; Parker M; Xue S; Wasserfall C; Haller MJ; Schatz D; Becker DJ; Atkinson MA; Mathews CE
    Diabetes; 2011 Aug; 60(8):2086-91. PubMed ID: 21659497
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Possible links between amylin and diabetes. Amylin is released into the blood stream along with insulin.
    Luskey KL
    Diabetes Care; 1992 Feb; 15(2):297-9. PubMed ID: 1547690
    [No Abstract]   [Full Text] [Related]  

  • 47. Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion.
    Festa A; Hanley AJ; Tracy RP; D'Agostino R; Haffner SM
    Circulation; 2003 Oct; 108(15):1822-30. PubMed ID: 14517163
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disruption of circadian rhythms accelerates development of diabetes through pancreatic beta-cell loss and dysfunction.
    Gale JE; Cox HI; Qian J; Block GD; Colwell CS; Matveyenko AV
    J Biol Rhythms; 2011 Oct; 26(5):423-33. PubMed ID: 21921296
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.
    DeFronzo RA
    Diabetes; 1988 Jun; 37(6):667-87. PubMed ID: 3289989
    [No Abstract]   [Full Text] [Related]  

  • 50. Hormonal responses and future treatment of non-insulin-dependent diabetes mellitus (NIDDM).
    Efendic S; Ostenson CG
    J Intern Med; 1993 Aug; 234(2):127-38. PubMed ID: 8101859
    [No Abstract]   [Full Text] [Related]  

  • 51. Circulating Retinol-Binding Protein 4 Is Inversely Associated With Pancreatic β-Cell Function Across the Spectrum of Glycemia.
    Huang R; Yin S; Ye Y; Chen N; Luo S; Xia M; Zhao L
    Diabetes Care; 2020 Jun; 43(6):1258-1265. PubMed ID: 32265192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decrease of stimulated amylin release precedes impairment of insulin secretion in type II diabetes.
    Ludvik B; Lell B; Hartter E; Schnack C; Prager R
    Diabetes; 1991 Dec; 40(12):1615-9. PubMed ID: 1756902
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between insulin resistance and β-cell dysfunction in subphenotypes of prediabetes and type 2 diabetes.
    Færch K; Johansen NB; Witte DR; Lauritzen T; Jørgensen ME; Vistisen D
    J Clin Endocrinol Metab; 2015 Feb; 100(2):707-16. PubMed ID: 25387263
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets.
    Ohsawa H; Kanatsuka A; Yamaguchi T; Makino H; Yoshida S
    Biochem Biophys Res Commun; 1989 Apr; 160(2):961-7. PubMed ID: 2655598
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel approaches to restore beta cell function in prediabetes and type 2 diabetes.
    Salunkhe VA; Veluthakal R; Kahn SE; Thurmond DC
    Diabetologia; 2018 Sep; 61(9):1895-1901. PubMed ID: 29947922
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhanced glucose-induced intracellular signaling promotes insulin hypersecretion: pancreatic beta-cell functional adaptations in a model of genetic obesity and prediabetes.
    Irles E; Ñeco P; Lluesma M; Villar-Pazos S; Santos-Silva JC; Vettorazzi JF; Alonso-Magdalena P; Carneiro EM; Boschero AC; Nadal Á; Quesada I
    Mol Cell Endocrinol; 2015 Mar; 404():46-55. PubMed ID: 25633666
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beta-Cell hyperplasia induced by hepatic insulin resistance: role of a liver-pancreas endocrine axis through insulin receptor A isoform.
    Escribano O; Guillén C; Nevado C; Gómez-Hernández A; Kahn CR; Benito M
    Diabetes; 2009 Apr; 58(4):820-8. PubMed ID: 19136656
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Persistence of pre-diabetes in overweight and obese Hispanic children: association with progressive insulin resistance, poor beta-cell function, and increasing visceral fat.
    Goran MI; Lane C; Toledo-Corral C; Weigensberg MJ
    Diabetes; 2008 Nov; 57(11):3007-12. PubMed ID: 18678615
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A heterogeneous response of liver and skeletal muscle fat to the combination of a Paleolithic diet and exercise in obese individuals with type 2 diabetes: a randomised controlled trial.
    Otten J; Stomby A; Waling M; Isaksson A; Söderström I; Ryberg M; Svensson M; Hauksson J; Olsson T
    Diabetologia; 2018 Jul; 61(7):1548-1559. PubMed ID: 29696296
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The beta-cell in type 2 diabetes and in obesity.
    Rutter GA; Parton LE
    Front Horm Res; 2008; 36():118-134. PubMed ID: 18230899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 89.